CRNX Crinetics Pharmaceuticals, Inc.
$43.48
▲ 4.23%
35
Value
14
P/E-9.12
8
P/B3.53
46
P/S288.23
0
EV/EBITDA-8.44
5
Growth
62
Revenue Growth640.7%
100
EPS Growth-34.1%
41
FCF Growth-67.0%
37
Momentum
63
12-Month Return42.5%
79
3-Month Return-2.9%
55
1-Month Return8.8%
69
RSI (14)62.20
73
50/200 MABearish
30
Profitability
21
ROE-44.0%
43
ROA-35.4%
0
Gross Margin101.6%
79
Operating Margin-3455.6%
0
Net Margin-3143.1%
0
FCF Yield-9.2%
0
Risk
16
Beta0.28
35
60-Day Volatility44.0%
0
QScore Analysis